Maksymilian Chruszcz Selected Research

holo-(acyl-carrier-protein) synthase

1/2018

Differences in substrate specificity of V. cholerae FabH enzymes suggest new approaches for the development of novel antibiotics and biofuels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maksymilian Chruszcz Research Topics

Disease

7	Hypersensitivity (Allergy) 01/2021 - 12/2013
5	Infections 10/2018 - 07/2011
3	Anaphylaxis (Anaphylactic Shock) 07/2022 - 12/2013
3	Neoplasms (Cancer) 01/2020 - 08/2008
2	COVID-19 09/2020 - 07/2020
2	Allergic Rhinitis 09/2020 - 01/2020
2	Asthma (Bronchial Asthma) 09/2020 - 03/2012
2	Cholera 01/2018 - 01/2016
2	Carcinogenesis 01/2015 - 02/2012
2	Leukemia 11/2012 - 09/2011
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Rhinitis 09/2020
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2015
1	Prostatic Neoplasms (Prostate Cancer) 03/2012
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 09/2011
1	Anthrax 07/2011
1	Cryptosporidiosis 12/2008
1	Neglected Diseases 12/2008
1	Type 2 Diabetes Mellitus (MODY) 01/2008
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2008
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2006

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2006
7	Immunoglobulin E (IgE)IBA 07/2022 - 01/2018
7	AllergensIBA 01/2022 - 03/2012
4	Pharmaceutical PreparationsIBA 09/2020 - 12/2008
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2020 - 07/2020
2	AlbuminsIBA 09/2020 - 07/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 09/2020 - 07/2020
2	Profilins (Profilin)IBA 01/2020 - 01/2020
2	VaccinesIBA 01/2020 - 07/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 09/2013
2	EWS-FLI fusion proteinIBA 01/2015 - 02/2012
1	Monoclonal AntibodiesIBA 07/2022
1	Dermatophagoides pteronyssinus antigen p 2IBA 07/2022
1	EpitopesIBA 07/2022
1	ParvalbuminsIBA 01/2022
1	GibberellinsIBA 01/2021
1	Dermatophagoides AntigensIBA 09/2020
1	AntibodiesIBA 01/2020
1	AntigensIBA 01/2020
1	holo-(acyl-carrier-protein) synthaseIBA 01/2018
1	Clindamycin (Cleocin)FDA LinkGeneric 01/2017
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2017
1	YK 4-279IBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	hypoxanthine arabinoside (ara-H)IBA 12/2013
1	Fusidic Acid (Fucithalmic)IBA 09/2013
1	Protein Isoforms (Isoforms)IBA 03/2012
1	Voltage-Gated Sodium ChannelsIBA 03/2012
1	Dermatophagoides farinae antigen f 1IBA 03/2012
1	Dermatophagoides pteronyssinus antigen p 1IBA 03/2012
1	RNA Helicases (RNA Helicase)IBA 02/2012
1	Intrinsically Disordered ProteinsIBA 02/2012
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 09/2011
1	prenylIBA 12/2008
1	Diphosphonates (Bisphosphonates)IBA 12/2008
1	TubulinIBA 08/2008
1	Biological ProductsIBA 08/2008
1	ResveratrolIBA 01/2008
1	Sirtuin 1IBA 01/2008

Therapy/Procedure

4	Therapeutics 09/2020 - 01/2015
2	Immunotherapy 01/2020 - 01/2018